Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
MERCK SHARP & DOHME (NEW ZEALAND) LIMITED,15-valent pneumococcal conjugate vaccine (PCV15),Prevention of invasive pneumococcal disease,15-valent pneumococcal conjugate vaccine (PCV15) (VAXNEUVANCE.),,Community,
